Barusiban, renowned for its selective and potent qualities, possesses the intriguing ability to act as an oxytocin receptor antagonist, rendering it a remarkable candidate within the biomedical realm. This exceptional substance finds its purpose in combating preterm labor and uterine hyperactivity, where it diligently undertakes the role of inhibiting uterine contractions. By skillfully delaying or even evading the occurrence of premature birth, Barusiban exhibits its profound impact on reproductive health.
CAT No: R2074
CAS No:285571-64-4
Chemical Name:(4S,7S,10S,13S,16R)-N-[(2S)-5-amino-1-hydroxypentan-2-yl]-7-(2-amino-2-oxoethyl)-13-[(2S)-butan-2-yl]-10-[(2R)-butan-2-yl]-16-(1H-indol-3-ylmethyl)-N-methyl-6,9,12,15,18-pentaoxo-1-thia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
2. High fat diet and GLP-1 drugs induce pancreatic injury in mice
5. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.